Boehringer Ingelheim

Boehringer and partners commence gene therapy trial for cystic fibrosis
Clinical Trials Arena
Fri, 02/21/25 - 10:49 am
Boehringer Ingelheim
gene therapy
cystic fibrosis
clinical trials
Boehringer eyes third quarter FDA verdict for oral HER2 drug
Pharmaphorum
Thu, 02/20/25 - 11:29 am
Boehringer Ingelheim
zongertinib
FDA
metastatic non-small cell lung cancer
ExpressionEdits and Boehringer Ingelheim partner to optimize gene therapies
Pharmaceutical Business Review
Fri, 02/14/25 - 09:15 am
Boehringer Ingelheim
ExpressionEdits
gene therapy
Boehringer's phase 3 schizophrenia program misses primary goal
Fierce Biotech
Thu, 01/16/25 - 09:39 pm
Boehringer Ingelheim
schizophrenia
clinical trials
iclepertin
Boehringer Ingelheim drops obesity drug from Gubra partnership
Fierce Biotech
Thu, 10/31/24 - 10:45 pm
Boehringer Ingelheim
Gubra
obesity
Notable Labs files for bankruptcy, ending ambitions for Boehringer cancer drug
Fierce Biotech
Tue, 10/15/24 - 10:17 am
Notable Labs
Boehringer Ingelheim
oncology
bankruptcy
volasertib
Boehringer unveils $607M deal to land Circle's preclinical cancer program
Fierce Biotech
Wed, 10/9/24 - 09:55 am
Boehringer Ingelheim
Circle Pharma
cancer
drug development
Boehringer kickstarts two Phase III trials as MASH therapy wins breakthrough status
Clinical Trials Arena
Tue, 10/8/24 - 09:56 am
Boehringer Ingelheim
MASH
clinical trials
survodutide
Weight loss gold rush: Developers vie for next blockbuster treatment
Pharmaphorum
Tue, 10/8/24 - 09:45 am
R&D
obesity
weight loss
Novo Nordisk
Eli Lilly
Roche
Boehringer Ingelheim
Boehringer Ingelheim and Veeva: A data partnership for One Medicine
Pharmaphorum
Fri, 10/4/24 - 09:18 am
Boehringer Ingelheim
Veeva
One Medicine Platform
Clinical Data
Boehringer's phase 3 lung fibrosis trial hits primary endpoint, teeing up filings for Ofev successor
Fierce Biotech
Mon, 09/16/24 - 10:57 am
Boehringer Ingelheim
IPF
clinical trials
nerandomilast
Boehringer Ingelheim reports positive results from trial of HER2 lung cancer drug
Clinical Trials Arena
Tue, 09/10/24 - 08:35 am
Boehringer Ingelheim
clinical trials
zongertinib
non-small cell lung cancer
Boehringer adds to cancer drug pipeline with deal for startup Nerio
BioPharma Dive
Mon, 07/29/24 - 11:01 am
Boehringer Ingelheim
M&A
Nerio Therapeutics
immuno-oncology
GoodRx teams with Boehringer on Humira biosimilar
Axios
Thu, 07/18/24 - 11:21 am
GoodRx
Boehringer Ingelheim
biosimilars
Humira
Boehringer backs Brainomix AI software for lung fibrosis
Pharmaphorum
Thu, 07/18/24 - 11:08 am
Boehringer Ingelheim
digital health
lung fibrosis
Brainomix
artificial intelligence
Boehringer Ingelheim Loses Legal Challenge to IRA in Federal Court Ruling
BioSpace
Mon, 07/8/24 - 11:38 am
Boehringer Ingelheim
Inflation Reduction Act
legal
Medicare
drug pricing
Boehringer Ingelheim and Gubra begin Phase I trial of drug candidate for obesity
Clinical Trials Arena
Tue, 07/2/24 - 11:19 am
Boehringer Ingelheim
Gubra
clinical trials
BI 3034701
obesity
With 2 planned launches, Boehringer Ingelheim looks to make a name for itself in oncology
Fierce Pharma
Mon, 06/10/24 - 06:07 pm
Boehringer Ingelheim
oncology
ASCO 2024
DDLPS
glioblastoma
Boehringer, Lilly face off in MASH at EASL
Pharmaphorum
Mon, 06/10/24 - 11:14 am
Eli Lilly
Boehringer Ingelheim
MASH
EASL
tirzepatide
survodutide
Boehringer, Zealand’s GLP-1 MASH Data ‘Unintentionally’ Published by Medical Congress Website
BioSpace
Thu, 06/6/24 - 11:48 am
Zealand Pharma
Boehringer Ingelheim
MASH
survodutide
clinical trials

Pages